Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management
Authors:
- Leonardo CalzaLCLeonardo Calza
- Roberto ManfrediRMRoberto Manfredi
- Francesco ChiodoFCFrancesco Chiodo
- 1 August 2003
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 22 (2) , 89-99
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Nutritional Alterations Associated With HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Hyperlipidemia Associated with HIV Protease Inhibitor Use: Pathophysiology, Prevalence, Risk Factors and TreatmentScandinavian Journal of Infectious Diseases, 2000
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Plasma lipids in HIV‐infected patients: a prospective study in 95 patientsEuropean Journal of Clinical Investigation, 1994
- Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infectionThe American Journal of Medicine, 1993
- Increased de novo hepatic lipogenesis in human immunodeficiency virus infectionThe Journal of Clinical Endocrinology & Metabolism, 1993
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeThe Journal of Clinical Endocrinology & Metabolism, 1992
- Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndromeThe American Journal of Medicine, 1991